Renew Biotechnologies: Steven Abbott

Renew Biotechnologies, a company specializing in next-generation sequencing-based diagnostics, has appointed Steven Abbott as chief operating officer. Abbott will head Renew subsidiary Wasatch BioLabs from as it transitions from its current R&D phase into full-scale commercial operations. Abbott most recently served as VP of lab operations at Flagship Biosciences. He has also held leadership positions at Q² Solutions, including director of genomics business development and director of global genomics lab operations.